loadpatents
name:-0.023329019546509
name:-0.01638388633728
name:-0.0041649341583252
COMBREDET; Chantal Patent Filings

COMBREDET; Chantal

Patent Applications and Registrations

Patent applications and USPTO patent grants for COMBREDET; Chantal.The latest application filed is for "compositions and methods comprising measles virus defective interfering particles for the prevention of infectious diseases".

Company Profile
3.20.21
  • COMBREDET; Chantal - Paris FR
  • Combredet; Chantal - Levallois N/A FR
  • Combredet; Chantal - Villiers FR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Compositions And Methods Comprising Measles Virus Defective Interfering Particles For The Prevention Of Infectious Diseases
App 20210252131 - TANGY; Frederic ;   et al.
2021-08-19
Compositions and methods comprising measles virus defective interfering particles for the prevention of infectious diseases
Grant 11,020,473 - Tangy , et al. June 1, 2
2021-06-01
Use of a genetically modified infectious measles virus with enhanced pro-apoptotic properties (MV-deltaC virus) in cancer therapy
Grant 10,980,873 - Tangy , et al. April 20, 2
2021-04-20
Use Of A Genetically Modified Infectious Measles Virus With Enhanced Pro-apoptotic Properties (mv-deltac Virus) In Cancer Therap
App 20200016260 - TANGY; Frederic ;   et al.
2020-01-16
Compositions And Methods Comprising Measles Virus Defective Interfering Particles For The Prevention Of Infectious Diseases
App 20190184003 - TANGY; Frederic ;   et al.
2019-06-20
Use of a genetically modified infectious measles virus with enhanced pro-apoptotic properties (MV-deltaC virus) in cancer therapy
Grant 10,314,905 - Tangy , et al.
2019-06-11
Chimeric poly peptides and the therapeutic use thereof against a flaviviridae infection
Grant 10,227,385 - Tangy , et al.
2019-03-12
Use Of A Genetically Modified Infectious Measles Virus With Enhanced Pro-apoptotic Properties (mv-deltac Virus) In Cancer Therapy
App 20180221469 - TANGY; Frederic ;   et al.
2018-08-09
Use of a genetically modified infectious measles virus with enhanced pro-apoptotic properties (MV-deltaC virus) in cancer therapy
Grant 9,889,193 - Tangy , et al. February 13, 2
2018-02-13
Infectious cDNA of an approved vaccine strain of measles virus, use for immunogenic compositions
Grant 9,701,944 - Tangy , et al. July 11, 2
2017-07-11
Chimeric Poly Peptides And The Therapeutic Use Thereof Against A Flaviviridae Infection
App 20170121375 - TANGY; Frederic ;   et al.
2017-05-04
Chimeric poly peptides and the therapeutic use thereof against a Flaviviridae infection
Grant 9,579,375 - Tangy , et al. February 28, 2
2017-02-28
Use Of A Genetically Modified Infectious Measles Virus With Enhanced Pro-apoptotic Properties (mv-deltac Virus) In Cancer Therapy
App 20150359873 - TANGY; Frederic ;   et al.
2015-12-17
Infectious Cdna Of An Approved Vaccine Strain Of Measles Virus, Use For Immunogenic Compositions
App 20150275184 - TANGY; Frederic ;   et al.
2015-10-01
Infectious cDNA of an approved vaccine strain of measles virus, use for immunogenic compositions
Grant 9,005,961 - Tangy , et al. April 14, 2
2015-04-14
Infectious cDNA of an approved vaccine strain of measles virus, use for immunogenic compositions
Grant 9,005,925 - Tangy , et al. April 14, 2
2015-04-14
Chimeric Poly Peptides And The Therapeutic Use Thereof Against A Flaviviridae Infection
App 20150071963 - TANGY; Frederic ;   et al.
2015-03-12
Dengue and West Nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications
Grant 8,859,240 - Tangy , et al. October 14, 2
2014-10-14
Chimeric poly peptides and the therapeutic use thereof against a flaviviridae infection
Grant 8,853,379 - Tangy , et al. October 7, 2
2014-10-07
Infectious cDNA of an approved vaccine strain of measles virus, use for immunogenic compositions
App 20130296541 - Tangy; Frederic ;   et al.
2013-11-07
Dengue And West Nile Viruses Proteins And Genes Coding The Foregoing, And Their Use In Vaccinal, Therapeutic And Diagnostic Applications
App 20130089558 - Tangy; Frederic ;   et al.
2013-04-11
Strain of SARS-associated coronavirus and applications thereof
Grant 8,343,718 - Van Der Werf , et al. January 1, 2
2013-01-01
Chimeric poly peptides and the therapeutic use thereof against a Flaviviridae infection
Grant 8,337,857 - Tangy , et al. December 25, 2
2012-12-25
Chimeric Poly Peptides And The Therapeutic Use Thereof Against A Flaviviridae Infection
App 20120201825 - TANGY; Frederic ;   et al.
2012-08-09
Use Of Proteins And Peptides Encoded By The Genome Of A Novel Sars-associated Coronavirus Strain
App 20120082693 - VAN DER WERF; Sylvie ;   et al.
2012-04-05
Novel Strain Of Sars-associated Coronavirus And Applications Thereof
App 20110065089 - Van Der Werf; Sylvie ;   et al.
2011-03-17
Chimeric Poly Peptides And The Therapeutic Use Thereof Against A Flaviviridae Infection
App 20100226924 - Tangy; Frederic ;   et al.
2010-09-09
Strain of SARS-associated coronavirus and applications thereof
Grant 7,736,850 - Van Der Werf , et al. June 15, 2
2010-06-15
Dengue and West Nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications
Grant 7,556,812 - Tangy , et al. July 7, 2
2009-07-07
Use Of Proteins And Peptides Encoded By The Genome Of A Novel Sars-Associated Coronavirus Strain
App 20070275002 - Van Der Werf; Sylvie ;   et al.
2007-11-29
Novel strain of sars-associated coronavirus and applications thereof
App 20070128224 - Van Der Werf; Sylvie ;   et al.
2007-06-07
Dengue and West Nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications
App 20060073164 - Tangy; Frederic ;   et al.
2006-04-06
Infectious cDNA of an approved vaccine strain of measles virus, use for immunogenic compositions
App 20050227224 - Tangy, Frederic ;   et al.
2005-10-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed